Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|October 4, 2021
DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung CancerJiawei Dai, Minlin Jiang, Kan He, et al.
Acta Pharmaceutica Sinica. B|November 3, 2021
Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapyMinlin Jiang, Keyi Jia, Lei Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 31, 2025
LncRNA THUMPD3-AS1 Regulates Behavioral and Synaptic Structural Abnormalities in Schizophrenia via miR-485-5p and ARHGAP8Xiaojuan Gong, Lingxi Chen, Xin Guo, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Changing profile of lung cancer clinical characteristics in China: Over 8-year population-based studyKandi Xu, Hao Wang, Simin Li, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 27, 2016
Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung AdenocarcinomaYayi He, Yan Wang, Theresa Boyle, et al.
Scientific Reports|September 22, 2017
Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern ChinaYayi He, Jie Zheng, Qian Zhang, et al.
Translational Lung Cancer Research|May 19, 2020
Immunotherapy as a treatment for small cell lung cancer: a case report and brief reviewYan Wu, Yu Liu, Chenglong Sun, et al.
Translational Oncology|October 4, 2024
Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancerXinyue Liu, Yan Kong, Youwen Qian, et al.
Translational Lung Cancer Research|July 23, 2021
Artificial intelligence-based analysis for immunohistochemistry staining of immune checkpoints to predict resected non-small cell lung cancer survival and relapseHaoyue Guo, Li Diao, Xiaofeng Zhou, et al.
Oncology Letters|February 6, 2018
Histone deacetylation, as opposed to promoter methylation, results in epigenetic <i>BIM</i> silencing and resistance to EGFR TKI in NSCLCMingchuan Zhao, Yishi Zhang, Jiayu Li, et al.
Pageof 16